Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.59 +0.10 (+1.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Syndax Pharmaceuticals (SNDX) Return on Sales [ROS] (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) posted Return on Sales [ROS] of -50.30% for Q3 2026, up 74.89 percentage points from -125.19% a year earlier and up 4.65 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Syndax Pharmaceuticals was -61.67%, up 213.45 percentage points year-over-year; for FY2025, it was -158.45%, up 1275.98 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +4549.73 percentage points (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' Return on Sales [ROS] was -1434.43% in FY2024 and 18.77% in FY2021 (+4726.94 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q4 2021.
  • On a year-over-year basis, Return on Sales [ROS] has increased in each of the last six quarters, with an average year-over-year change of +455.38 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2021, with a gain of 5301.96 percentage points; the weakest was Q2 2024, with a drop of 1996.39 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -54.95% (Q2 2026), -52.73% (Q1 2026) and -91.01% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn -50.30%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -50.30%
Jun 30, 2026 -54.95%
Mar 31, 2026 -52.73%
Dec 31, 2025 -91.01%
Sep 30, 2025 -125.19%
Jun 30, 2025 -182.71%
Mar 31, 2025 -417.91%
Dec 31, 2024 -1,254.75%
Sep 30, 2024 -716.62%
Jun 30, 2024 -2,120.46%
Dec 31, 2023 -181.67%
Sep 30, 2023 -139.68%
Jun 30, 2023 -124.07%
Dec 31, 2021 75.65%
Sep 30, 2021 -161.87%
Jun 30, 2021 -5,892.88%
Mar 31, 2021 -7,167.02%
Dec 31, 2020 -5,226.32%
Sep 30, 2020 -5,238.26%
Jun 30, 2020 -4,382.59%
API Access

Syndax Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNDX&period=max&api_key=YOUR_API_KEY